Echo Therapeutics(美国)

Echo Therapeutics

,EchoTherapeutics,www.echotx.com成立于1989年，总部设于美国费城，主要研发非侵入性无线透皮式动态血糖监测系统(CGM)，包括无针型Symphony CGMSystem以及用于透皮给药的PreludeSkinPrepSystem。CGM是一种会发出微小电脉到皮肤，用感应器检测出血糖通过毛细血管的扩散，使血糖读数发送到无线手持仪器之产品。产品主要应用于医院中糖尿病人之 临床的设置。EchoTherapeuticsisdevelopingtheSymphonyCGMSystemasanon-invasive,wireless,continuousglucosemonitoringsystem.Ourtargetispatientswhocouldbenefitfromglucosemonitoringinthehospitalsetting,includingcriticalcare.SignificantopportunityalsoexistsforpatientswithdiabetestouseSymphonyintheoutpatientsetting.Echoisalsodevelopingitsneedle-freeskinpreparationcomponentofSymphony,thePrelude®SkinPrepSystem,asaplatformtechnologytoenhancedrugdeliveryoftopicalpharmaceuticals.